Format
Items per page

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Hereditary factor XI deficiency disease

Factor XI deficiency is an autosomal bleeding disorder characterized by reduced levels of factor XI in plasma (less than 15 IU/dL). Bleeding occurs mainly after trauma or surgery. On the basis of the concordance or discordance of F11 antigen and activity, the disorder is classified into the more frequent cross-reactive negative (CRM-) and the rarer CRM positive (CRM+) (summary by Duga and Salomon, 2009). [from GTR]

MedGen UID:
8770
Concept ID:
C0015523
Disease or Syndrome
2.

Factor XI Deficiency

A coagulation disorder characterized by the partial or complete absence of factor XI activity in the blood. [from NCI]

MedGen UID:
1386956
Concept ID:
C4321502
Disease or Syndrome
3.

Reduced factor XI activity

MedGen UID:
1368629
Concept ID:
C4317093
Finding
4.

Much

A subjective response indicating that something is or was a large amount. [from NCI]

MedGen UID:
923949
Concept ID:
C4281574
Finding
5.

Difficult

A response indicating that something is or was difficult. [from NCI]

MedGen UID:
568202
Concept ID:
C0332218
Finding
6.

Functional disorder

Deranged function in an individual or an organ that is due to a disease. (MedicineNet.com) [from NCI]

MedGen UID:
124450
Concept ID:
C0277785
Pathologic Function
7.

Frequent

Coming at short intervals or in great quantities. [from NCI]

MedGen UID:
87144
Concept ID:
C0332183
Temporal Concept
8.

Hemorrhage

Bleeding or escape of blood from a vessel. [from MeSH]

MedGen UID:
5503
Concept ID:
C0019080
Pathologic Function
9.

Fibrin Modulating Agents

Agents that affect the function of FIBRIN in BLOOD COAGULATION. They used as COAGULANTS for HEMORRHAGE or ANTICOAGULANTS for THROMBOSIS. [from MeSH]

MedGen UID:
327603
Concept ID:
C1563784
Pharmacologic Substance
10.

Molecular Mechanisms of Pharmacological Action

Pharmacological activities at the molecular level of DRUGS and other exogenous compounds that are used to treat DISEASES and affect normal BIOCHEMISTRY. [from MeSH]

MedGen UID:
226255
Concept ID:
C1258062
Molecular Function
11.

Inborn genetic diseases

Diseases that are caused by genetic mutations present during embryo or fetal development, although they may be observed later in life. The mutations may be inherited from a parent's genome or they may be acquired in utero. [from MeSH]

MedGen UID:
181981
Concept ID:
C0950123
Disease or Syndrome
12.

Blood Coagulation Disorders, Inherited

Hemorrhagic and thrombotic disorders that occur as a consequence of inherited abnormalities in blood coagulation. [from MeSH]

MedGen UID:
163105
Concept ID:
C0852077
Disease or Syndrome
13.

Coagulation Protein Disorders

Hemorrhagic and thrombotic disorders resulting from abnormalities or deficiencies of coagulation proteins. [from MeSH]

MedGen UID:
108723
Concept ID:
C0600503
Disease or Syndrome
14.

Antihemorrhagics

MedGen UID:
88469
Concept ID:
C0085824
Pharmacologic Substance
15.

Hemostatic agent

Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. [from MeSH]

MedGen UID:
42410
Concept ID:
C0019120
Pharmacologic Substance
16.

Postoperative hemorrhage

Bleeding occurring after completion of a surgical procedure, which may occur immediately or may be delayed, and which may or may not be wound related. [from NCI]

MedGen UID:
18591
Concept ID:
C0032788
Pathologic Function
17.

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Diseases existing at birth and often before birth, or that develop during the first month of life (INFANT, NEWBORN, DISEASES), regardless of causation. Of these diseases, those characterized by structural deformities are termed CONGENITAL ABNORMALITIES. [from MeSH]

MedGen UID:
14319
Concept ID:
C0027612
Congenital Abnormality; Disease or Syndrome
18.

Pregnancy

The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth. [from NCI]

MedGen UID:
10895
Concept ID:
C0032961
Organism Function
19.

Postoperative complication

Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. [from MeSH]

MedGen UID:
10871
Concept ID:
C0032787
Pathologic Function
20.

Hematologic agent

Drugs that act on blood and blood-forming organs and those that affect the hemostatic system. [from MeSH]

MedGen UID:
9187
Concept ID:
C0018938
Pharmacologic Substance
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center